Join
Live feed
·
INSIDERFilingvia Quantisnow
Kiniksa Pharmaceuticals International plc logo

CHIEF OPERATING OFFICER Tessari Eben exercised 23,300 units of Class A Ordinary Share at a strike of $10.04, covered exercise/tax liability with 3,972 units of Class A Ordinary Share and sold $535,730 worth of Class A Ordinary Share (15,091 units at $35.50), increasing direct ownership by 11% to 44,452 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KNSA (Kiniksa Pharmaceuticals International plc) and more on Quantisnow.